These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34361998)

  • 21. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
    Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
    Front Public Health; 2022; 10():832003. PubMed ID: 35400056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The COVID-19 wave was already here: High seroprevalence of SARS-CoV-2 antibodies among staff and students in a Cameroon University.
    Deutou Wondeu AL; Talom BM; Linardos G; Ngoumo BT; Bello A; Ndassi Soufo AM; Momo AC; Doll C; Tamuedjoun AT; Kiuate JR; Cappelli G; Russo C; Perno CF; Tchidjou HK; Scaramella L; Galgani A
    J Public Health Afr; 2023 Jan; 14(1):2242. PubMed ID: 36798849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Seroprevalence: Demographic and Behavioral Factors Associated With Seropositivity Among College Students in a University Setting.
    Diepstra K; Bullington BW; Premkumar L; Shook-Sa BE; Jones C; Pettifor A
    J Adolesc Health; 2022 Nov; 71(5):559-569. PubMed ID: 35985917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SARS-CoV-2 Exposure and Seroprevalence of SARS-CoV-2 Antibodies among Medical Students in the First Phase of the Pandemic 2020-2021].
    Landmesser P; Weissbrich B; Peter-Kern M; Krone M; Liese JG; Streng A
    Gesundheitswesen; 2024 Apr; 86(4):311-314. PubMed ID: 38181814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
    Ladoire S; Goussot V; Redersdorff E; Cueff A; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hanu R; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
    Eur J Cancer; 2021 May; 148():359-370. PubMed ID: 33780664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
    Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
    Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students.
    Kianersi S; Ludema C; Macy JT; Garcia Colato E; Chen C; Luetke M; Lown MH; Rosenberg M
    J Adolesc Health; 2021 Aug; 69(2):219-226. PubMed ID: 34112598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
    Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
    J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W; Abidi SHB; Baqar JB
    BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 seroprevalence at urban and rural sites in Kaduna State, Nigeria, during October/November 2021, immediately prior to detection of the Omicron variant.
    Chechet GD; Kwaga JKP; Yahaya J; Noyes H; MacLeod A; Adamson WE
    Int J Epidemiol; 2022 Oct; 51(5):1361-1370. PubMed ID: 35771662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
    Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
    Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members.
    Arnold CRK; Srinivasan S; Rodriguez S; Rydzak N; Herzog CM; Gontu A; Bharti N; Small M; Rogers CJ; Schade MM; Kuchipudi SV; Kapur V; Read A; Ferrari MJ
    medRxiv; 2021 Sep; ():. PubMed ID: 33619497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru.
    Reyes-Vega MF; Soto-Cabezas MG; Cárdenas F; Martel KS; Valle A; Valverde J; Vidal-Anzardo M; Falcón ME; Munayco CV;
    EClinicalMedicine; 2021 Apr; 34():100801. PubMed ID: 33817611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil.
    França PC; Silva PGB; Rocha JLC; Perdigão ACB; Oliveira NS; Araújo FMC; Fonseca MHG; Lima GRP; Almeida MM; Alencar CH; Oliveira WK; Cavalcanti LPG
    Rev Soc Bras Med Trop; 2022; 55():e06062021. PubMed ID: 35522813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.